Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02037880 · ClinicalTrials.gov registry record
Natural History Studies of Mucopolysaccharidosis III
A clinical trial, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 25
- Enrollment target
NCT02037880: Completed study, sponsored by Nationwide Children's Hospital.
NCT02037880 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02037880 has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to assess rates of decline in motor and cognitive functional measures, and to assess potential biomarkers, in order to identify potential outcome measure appropriate for use in therapeutic clinical trials.
Primary Outcome
Assessed using the Leiter International Performance assessment, a non-verbal assessment of cognitive function.
Interventions
- PROCEDURE Lumbar puncture
- DEVICE Magnetic Resonance Imaging (MRI) of the brain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-11 |
What the finished NCT02037880 record still lists
NCT02037880 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Lumbar puncture is the first listed.
NCT02037880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02037880 about?
NCT02037880 is a clinical study titled "Natural History Studies of Mucopolysaccharidosis III". The purpose of this study is to assess rates of decline in motor and cognitive functional measures, and to assess potential biomarkers, in order to identify potential outcome measure appropriate for use in therapeutic clinical trials.
What is the current status of trial NCT02037880?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2014-02. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02037880?
The interventions under investigation include: Lumbar puncture (PROCEDURE), Magnetic Resonance Imaging (MRI) of the brain (DEVICE).
Who is sponsoring clinical trial NCT02037880?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia